Moneycontrol PRO
Upcoming Event:Attend Algo Convention Live, 2 Days & 12+ Speakers at best offer Rs.999/-, exclusive for Moneycontrol Pro subscribers. Register now!
you are here: HomeNewsIndia

India tells overseas vaccine buyers it has to prioritise local needs

Reports that India will delay deliveries of AstraZeneca’s COVID-19 vaccine to a global programme to inoculate poorer countries triggered alarm on Thursday, with the head of Africa’s disease control agency describing the continent as “helpless”.

March 27, 2021 / 11:38 AM IST
A healthcare worker receives a dose of Covishield at a government-run hospital at Baruipur on the outskirts of Kolkata. (Image: Reuters)

A healthcare worker receives a dose of Covishield at a government-run hospital at Baruipur on the outskirts of Kolkata. (Image: Reuters)


India, the world’s biggest vaccine maker, said on Friday it would make domestic COVID-19 inoculations a priority as infections surge and had told international buyers of its decision.

Reports that India will delay deliveries of AstraZeneca’s COVID-19 vaccine to a global programme to inoculate poorer countries triggered alarm on Thursday, with the head of Africa’s disease control agency describing the continent as “helpless”.


India has exported 60.5 million doses, more than the number of inoculations conducted at home, and says there is no outright ban on exports.


“In the coming weeks and months ... obviously there will be a demand spike and obviously people are preparing for it,” Subrahmanyam Jaishankar, the minister of external affairs, told the Times Network’s India Economic Enclave.


“In many cases, we have told our international partners that ... COVID rates are going up in India, we are expanding our own vaccination ambit, so we are sure you will understand that at this time we have to purpose it much more focused at where we are.”


The Gavi alliance said in a statement that the COVAX vaccine-sharing facility had notified all affected economies of potential delays of exports by the Serum Institute of India (SII).

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

India is diverting more supplies from SII to inoculations at home. Its other vaccine maker, Bharat Biotech, is struggling to boost output.


“SII has pledged that, alongside supplying India, it will prioritize the COVAX multilateral solution for equitable distribution,” Gavi said.


COVAX is a global vaccine allocation plan co-led by the World Health Organization and partners including the Gavi alliance.


India on Friday reported 59,118 new infections, taking its tally to 11.85 million. The death toll rose by 257 to stand at 160,949.


Everyone above 45 in India is eligible for vaccination from April 1 and the government is considering including more people after new infections nearly quadrupled this month.


“The government is already planning to widen the umbrella of COVID-19 vaccine beneficiaries in the near future to cover other sections of our population,” Health Minister Harsh Vardhan told a virtual summit organised by the Economic Times newspaper.


India has injected 55 million vaccine doses, the third highest figure after the United States and Brazil, although much lower as a proportion of its population of 1.35 billion, the website Our World in Data showed.


The western state of Maharashtra, hardest hit by a resurgence in cases, has warned of vaccine shortages and imposed lockdowns in some towns.


Maharashtra Chief Minister Uddhav Thackeray said the state government would impose a night curfew from Sunday to stem the spread of the coronavirus, and authorities could also impose local lockdowns in some districts after informing people in advance. In another measure, the state will shut shopping malls from 7 p.m. until 6 a.m. local time.


Thackeray said although his government has beefed up health-care facilities, rising coronavirus cases could overwhelm hospitals.


Maharashtra’s Pune district on Thursday reported a record 6,427 new cases, the highest in the country.


“If the current surge in coronavirus cases remains there for the next few days, there will be no option but to impose a strict lockdown in Pune from April 2,” Maharashtra’s deputy chief minister, Ajit Pawar, told a news conference.

Separately, a fire in one hospital near Mumbai killed at least nine coronavirus patients.



Download your money calendar for 2022-23 here and keep your dates with your moneybox, investments, taxes

Reuters
first published: Mar 27, 2021 11:38 am
Sections
ISO 27001 - BSI Assurance Mark